| Gene symbol | CD70 | Synonyms | CD27-L, CD27L, CD27LG, LPFS3, TNFSF7, TNLG8A | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19p13.3 | dbXrefs | |
| Description | CD70 molecule | ||||
| GTO ID | GTC3725 |
| Trial ID | NCT06215950 |
| Disease | Ovarian Cancer | Cervix Cancer | Advanced Cancer | Gynecologic Cancer |
| Altered gene | CD70 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD70 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Phase I Clinical Study to Assess the Safety and Efficacy of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer |
| Year | 2024 |
| Country | China |
| Company sponsor | Chongqing Precision Biotech Co., Ltd |
| Other ID(s) | PBC061 |
| Cohort 1 | |||||||||||
|
|||||||||||